AusPAR: Ustekinumab

Australian Public Assessment Report

AusPAR

AusPAR: Ustekinumab [PDF, 812.5 KB]

AusPAR: Ustekinumab [Word, 508.51 KB]

Attachment: Product Information: Ustekinumab [PDF, 528.43 KB]

Attachment: Product Information: Ustekinumab [Word, 604.71 KB]

Attachment: Extract from Clinical Evaluation Report: Ustekinumab [PDF, 3.35 MB]

Attachment: Extract from Clinical Evaluation Report: Ustekinumab [Word, 8.2 MB]

Device/Product Name

Stelara

Active ingredients

Ustekinumab

AusPAR Date

24 October 2017

Published

6 November 2017

Submission Number

PM-2015-04746-1-1

Submission Type

Extension of indications, New dosage strength and Route of administration

Decision

Approved